trending Market Intelligence /marketintelligence/en/news-insights/trending/3rr0idckbo4kknr0wdly5g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

OptimizeRx names board members

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

OptimizeRx names board members

OptimizeRx Corp. appointed Patrick Spangler and Bryan Archambault to its board.

Spangler succeeds Jack Pinney, who was appointed the head of the company's medical advisory board. Spangler is the CFO of VigiLanz, a digital healthcare intelligence firm, and is a board member of Lifespace Communities.

Archambault replaces Lynn O'Connor Vos as representative of WPP, a strategic investor in OptimizeRx. Archambault serves as the chief marketing officer of WPP unit greyhealth group, or ghg, Kansas City.

Vos left her position as CEO of greyhealth group to become CEO of the Muscular Dystrophy Association. She will remain on OptimizeRx's board as an independent director.

Rochester, Mich.-based OptimizeRx provides digital health messaging services, providing a direct channel for pharmaceutical companies to communicate with healthcare providers.